Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

The relationship between anemia, serum hepcidin levels, and chronic hepatitis C in chronic hemodialysis patients

The Egyptian Journal of Internal Medicine volume 29, pages 112–116 (2017)Cite this article

Abstract

Background

Hepcidin is a small peptide that is produced by hepatocytes and circulates in the plasma. It plays a central role in regulating the iron status in the body.

Aim

The aim of this study was to measure serum hepcidin levels in maintenance hemodialysis (MHD) patients and identify a possible impact of chronic hepatitis C virus (HCV) infection on the severity of anemia.

Patients and methods

This cross-sectional study was conducted on a cohort of 80 MHD patients (40 HCV positive and 40 HCV negative) and 20 healthy age-matched and sex-matched participants who participated as normal controls. Serum hepcidin and highly-sensitive C-reactive protein were measured in patients to study their possible effect on hematological and inflammatory parameters when compared with the control group.

Results

MHD patients had significantly higher serum hepcidin levels than did controls. The HCV-positive group had significantly lower serum hepcidin and ferritin levels when compared with the HCV-negative group. All MHD patients had significantly higher levels of serum highly-sensitive C-reactive protein than did controls. Hepcidin was also found to correlate with age and serum ferritin levels among MHD patients.

Conclusion

Changes in serum hepcidin levels are associated with iron status and microinflammation in MHD patients. If used as a diagnostic tool, it may improve targeting and timing of iron therapy by identifying patients during periods of reticuloendothelial blockage of iron transport. This is important to avoid iron overload, especially in HCV-positive patients, which may otherwise cause liver injury resulting in fibrosis, cirrhosis, and finally HCC. We also revealed the value of ferritin levels, which seemed to play an important role in determining the severity of liver disease related to liver fibrosis and microinflammatory activity.

References

  1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinan human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316:73–78.

    Article  CAS  Google Scholar 

  2. Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant 2002; 17(Suppl 1):53–59.

    Article  CAS  Google Scholar 

  3. Barany P, Divino Filho JC, Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29:565–568.

    Article  CAS  Google Scholar 

  4. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101:2461–2463.

    Article  CAS  Google Scholar 

  5. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99:4596–4601.

    Article  CAS  Google Scholar 

  6. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, et al. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol 2010; 5:1010–1014.

    Article  Google Scholar 

  7. Altintepe L, Kurtoglu E, Tonbul Z, Yeksan M, Yildiz A, Türk S. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection. Clin Nephrol 2004; 61:347–351.

    Article  CAS  Google Scholar 

  8. Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, et al. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest 2009; 39:883–890.

    Article  CAS  Google Scholar 

  9. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010; 120: 2395–2405.

    Article  Google Scholar 

  10. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009; 75:976–981.

    Article  CAS  Google Scholar 

  11. Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, et al. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat 2010; 17:800–806.

    Article  CAS  Google Scholar 

  12. Zhang P, Yang LN, Wang G, Li FE, Tang F. Serum hepcidin level and its clinical significance in maintenance hemodialysis patients. Genet Mol Res 2014; 13:9883–9888.

    Article  CAS  Google Scholar 

  13. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006; 55:667–674.

    CAS  PubMed  Google Scholar 

  14. Sezgin N, Zumrutdal A. The relationship between anemia, liver disease, and hepcidin levels in hemodialysis patients with hepatitis. Indian J Nephrol 2012; 22:415–418.

    Article  Google Scholar 

  15. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113:1271–1276.

    Article  CAS  Google Scholar 

  16. Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz A. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C. BMC Nephrol 2012; 13:56.

    Article  CAS  Google Scholar 

  17. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TfR2-hemochromatosis. Blood 2005; 105:1803–1806.

    Article  CAS  Google Scholar 

  18. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H,et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13:97–104.

    Article  CAS  Google Scholar 

  19. Amin NF, Ahmed HM, Tony EA, Galal GM, Mohammed OA, Abdel-Al AM, Mahmoud AA. Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients. Med J Cairo Univ 2010; 78:623–629.

    Google Scholar 

  20. Xu Y, Ding XQ, Zou JZ, Liu ZH, Jiang SH, Chen YM. Serum hepcidin in haemodialysis patients: associations withiron status and microinflammation J Int Med Res 2011; 39:1961–1967.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Fayoum University, Fayoum, Egypt

    Maher A. Al-Amir & Heba M. Zein Elabdin

  2. Department of Clinical Pathology, Fayoum University, Fayoum, Egypt

    Shahira M. Elshafie

  3. Department of Nephrology, Fayoum General Hospital, Fayoum, Egypt

    Sara A. Taha

  4. Department of Internal Medicine, Cairo University, 11562, Cairo, Egypt

    Ahmed A. Hassan (MD)

Authors
  1. Maher A. Al-Amir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed A. Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shahira M. Elshafie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heba M. Zein Elabdin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sara A. Taha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed A. Hassan.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Amir, M.A., Hassan, A.A., Elshafie, S.M. et al. The relationship between anemia, serum hepcidin levels, and chronic hepatitis C in chronic hemodialysis patients. Egypt J Intern Med 29, 112–116 (2017). https://doi.org/10.4103/ejim.ejim_28_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_28_17

Keywords